Thursday, June 1, 2023 | Back issues
Courthouse News Service Courthouse News Service

Big Pharma

NEW HAVEN - Boehringer Ingelheim Pharma and Teva colluded to exclude generic competition for Aggrenox, a federal antitrust complaint claims in a request for treble damages.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.